Gs Investments, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gs Investments, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$270,000
-24.8%
20,0000.0%0.13%
-30.3%
Q3 2021$359,000
+11.8%
20,000
+5.8%
0.19%
-39.5%
Q4 2020$321,000
-100.0%
18,900
-65.1%
0.31%
-68.9%
Q2 2020$1,255,272,000
+29.7%
54,2000.0%1.00%
+5.3%
Q1 2020$967,470,000
-63.2%
54,200
+0.6%
0.95%
-56.4%
Q4 2019$2,631,937,000
+166.6%
53,900
-0.6%
2.18%
+201.5%
Q3 2019$987,253,000
-48.8%
54,2000.0%0.72%
-54.2%
Q2 2019$1,928,436,000
+5.9%
54,2000.0%1.58%
+10.4%
Q1 2019$1,821,120,000
+2.6%
54,200
+0.4%
1.43%
-4.1%
Q4 2018$1,774,980,000
-46.1%
54,0000.0%1.49%
-35.3%
Q3 2018$3,291,840,000
+24.8%
54,0000.0%2.30%
+16.9%
Q2 2018$2,636,820,000
-52.3%
54,000
+3.8%
1.97%
-51.4%
Q1 2018$5,525,520,000
+63.0%
52,000
-8.4%
4.05%
+56.5%
Q4 2017$3,389,707,000
+148.6%
56,760
-0.1%
2.59%
+136.6%
Q3 2017$1,363,440,000
+35.5%
56,810
+10.4%
1.09%
+45.0%
Q2 2017$1,006,043,00051,4600.75%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders